• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下肢血管腔内血管重建的结果:潜在的预测因素和预防策略。

Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.

机构信息

Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Cardiovascular Internal Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

出版信息

Int J Mol Sci. 2021 Feb 18;22(4):2002. doi: 10.3390/ijms22042002.

DOI:10.3390/ijms22042002
PMID:33670461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7922574/
Abstract

Peripheral artery disease (PAD) is a manifestation of atherosclerosis, which may affect arteries of the lower extremities. The most dangerous PAD complication is chronic limb-threatening ischemia (CLTI). Without revascularization, CLTI often causes limb loss. However, neither open surgical revascularization nor endovascular treatment (EVT) ensure long-term success and freedom from restenosis and revascularization failure. In recent years, EVT has gained growing acceptance among all vascular specialties, becoming the primary approach of revascularization in patients with CLTI. In clinical practice, different clinical outcomes after EVT in patients with similar comorbidities undergoing the same procedure (in terms of revascularization technique and localization of the disease) cause unsolved issues that need to be addressed. Nowadays, risk management of revascularization failure is one of the major challenges in the vascular field. The aim of this literature review is to identify potential predictors for lower extremity endovascular revascularization outcomes and possible prevention strategies.

摘要

外周动脉疾病(PAD)是动脉粥样硬化的一种表现形式,可能会影响下肢的动脉。PAD 最危险的并发症是慢性肢体威胁性缺血(CLTI)。如果不进行血运重建,CLTI 常导致肢体丧失。然而,开放手术血运重建或血管内治疗(EVT)都不能确保长期成功和免于再狭窄及血运重建失败。近年来,EVT 在所有血管专业中越来越被接受,成为 CLTI 患者血运重建的主要方法。在临床实践中,对于接受相同手术(在血运重建技术和疾病定位方面)且具有相似合并症的患者,EVT 后的不同临床结局导致了一些悬而未决的问题,需要加以解决。如今,血运重建失败的风险管理是血管领域的主要挑战之一。本文献综述的目的是确定下肢血管腔内血运重建结局的潜在预测因素和可能的预防策略。

相似文献

1
Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.下肢血管腔内血管重建的结果:潜在的预测因素和预防策略。
Int J Mol Sci. 2021 Feb 18;22(4):2002. doi: 10.3390/ijms22042002.
2
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.对于因膝下动脉疾病导致慢性肢体威胁性缺血的患者,采用旁路优先与血管内优先策略的临床结果。
J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244.
3
Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.下肢动脉疾病初次血运重建策略中旁路和血管内介入治疗的患者选择和围手术期结局。
J Vasc Surg. 2018 Jan;67(1):206-216.e2. doi: 10.1016/j.jvs.2017.05.132. Epub 2017 Aug 24.
4
Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.下肢血运重建治疗慢性肢体威胁性缺血后双重抗血小板治疗的影响
J Vasc Surg. 2021 Oct;74(4):1327-1334. doi: 10.1016/j.jvs.2021.04.067. Epub 2021 May 20.
5
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.系统评价和荟萃分析显示,血运重建治疗下肢慢性肢体威胁性缺血的效果。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S110-S119. doi: 10.1016/j.ejvs.2019.04.013. Epub 2019 Jun 17.
6
Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.有或无既往血运重建的患者行股腘动脉旁路移植术的围手术期结局
J Vasc Surg. 2017 May;65(5):1354-1365.e2. doi: 10.1016/j.jvs.2016.10.114. Epub 2017 Feb 9.
7
Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.下肢血运重建术治疗人类免疫缺陷病毒(HIV)感染者的趋势和围手术期结果。
Vasc Med. 2020 Dec;25(6):527-533. doi: 10.1177/1358863X20952856. Epub 2020 Oct 6.
8
Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.高龄患者下肢慢性肢体威胁性缺血的血运重建。
Ann Vasc Surg. 2021 Apr;72:517-528. doi: 10.1016/j.avsg.2020.08.135. Epub 2020 Sep 12.
9
In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.下肢血运重建术后 30 天内住院期间与出院后主要不良事件比较。
J Vasc Surg. 2019 Feb;69(2):482-489. doi: 10.1016/j.jvs.2018.06.207. Epub 2018 Oct 6.
10
Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.慢性肢体严重缺血患者行下肢血运重建术后的生存预测。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S120-S134.e3. doi: 10.1016/j.ejvs.2019.04.009. Epub 2019 May 28.

引用本文的文献

1
Comparing the Impact of DOACs and Warfarin on Below-the-Knee Autologous Vein Bypass Patency in Peripheral Artery Disease: A Retrospective Cohort Study with 2-Year Follow-Up.比较直接口服抗凝剂(DOACs)和华法林对周围动脉疾病患者膝下自体静脉搭桥通畅率的影响:一项为期2年随访的回顾性队列研究。
J Pers Med. 2025 Jul 7;15(7):292. doi: 10.3390/jpm15070292.
2
Rheocarna treatment for non-dialysis patients.用于非透析患者的流变卡纳治疗。
Ther Apher Dial. 2025 Aug;29(4):588-592. doi: 10.1111/1744-9987.70024. Epub 2025 Apr 14.
3
Association of Klotho and FGF23 with cardiovascular outcomes in diabetic older adults with chronic limb-threatening ischemia: a prospective study.

本文引用的文献

1
Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.在糖尿病患者下肢血管腔内再通术后,网膜素-1 与主要心血管事件的关系:一项前瞻性队列研究。
Cardiovasc Diabetol. 2020 Oct 7;19(1):170. doi: 10.1186/s12933-020-01151-z.
2
Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study.在接受血运重建治疗的外周动脉疾病合并糖尿病患者中,Sortilin 水平与主要心血管事件相关:一项前瞻性研究。
Cardiovasc Diabetol. 2020 Sep 25;19(1):147. doi: 10.1186/s12933-020-01123-3.
3
在患有慢性肢体威胁性缺血的老年糖尿病患者中,klotho和FGF23与心血管结局的关联:一项前瞻性研究。
Geroscience. 2025 Apr 9. doi: 10.1007/s11357-025-01638-1.
4
Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.非传统动脉粥样硬化疾病中的残余传统风险。
Int J Mol Sci. 2025 Jan 10;26(2):535. doi: 10.3390/ijms26020535.
5
Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty.非胰岛素依赖型胰岛素抵抗指数与药物涂层球囊血管成形术后下肢动脉再狭窄的相关性
Lipids Health Dis. 2024 Dec 18;23(1):403. doi: 10.1186/s12944-024-02394-5.
6
Evaluation of sirtuin 1 as a predictor of cardiovascular outcomes in diabetic patients with limb-threatening ischemia.评估 SIRT1 作为伴有肢体威胁性缺血的糖尿病患者心血管结局的预测因子。
Sci Rep. 2024 Nov 6;14(1):26940. doi: 10.1038/s41598-024-78576-z.
7
External Scaffold for Venous Graft to Treat Chronic Limb-Threatening Ischemia: Results of the FRAME Vascular Support.用于治疗慢性肢体威胁性缺血的静脉移植物外部支架:FRAME血管支持的结果
J Clin Med. 2024 Apr 3;13(7):2095. doi: 10.3390/jcm13072095.
8
Predicting outcomes following lower extremity open revascularization using machine learning.使用机器学习预测下肢开放性血管重建术后的结果。
Sci Rep. 2024 Feb 5;14(1):2899. doi: 10.1038/s41598-024-52944-1.
9
Revascularization Outcomes Stratified by Glycemic Control in Patients with Diabetes Mellitus and Chronic Limb-Threatening Ischemia.糖尿病合并慢性肢体威胁性缺血患者的血糖控制分层的血运重建结果。
Ann Vasc Surg. 2024 Mar;100:91-100. doi: 10.1016/j.avsg.2023.10.018. Epub 2023 Dec 18.
10
Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation.当前下肢外周动脉疾病的医学治疗和血运重建:对亚临床慢性炎症的影响。
Int J Mol Sci. 2023 Nov 8;24(22):16099. doi: 10.3390/ijms242216099.
Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
编辑精选——BASIL-1 试验中全球肢体解剖分期系统(GLASS)与下肢严重缺血性病变的旁路与血管成形术比较(BASIL)-1 试验中慢性肢体威胁性缺血再血管化后的临床结果之间的关系。
Eur J Vasc Endovasc Surg. 2020 Nov;60(5):687-695. doi: 10.1016/j.ejvs.2020.06.042. Epub 2020 Aug 7.
4
Modern treatment of chronic limb-threatening ischemia requires a PLAN, clinical judgment, and shared decision making.现代慢性肢体威胁性缺血的治疗需要一个计划、临床判断和共同决策。
J Vasc Surg. 2020 Aug;72(2):389-390. doi: 10.1016/j.jvs.2020.01.055.
5
Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.药物涂层球囊血管成形术在真实世界股腘动脉队列中的三年持续临床疗效
J Endovasc Ther. 2020 Oct;27(5):693-705. doi: 10.1177/1526602820931477. Epub 2020 Jun 25.
6
Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.术前血糖控制对下肢动脉疾病糖尿病患者血管内治疗临床结局的影响:来自韩国多中心回顾性登记队列的分析。
Cardiovasc Diabetol. 2020 Jun 22;19(1):97. doi: 10.1186/s12933-020-01072-x.
7
Implications of Renal Disease in Patients Undergoing Peripheral Arterial Interventions.肾脏疾病对接受外周动脉介入治疗患者的影响。
Interv Cardiol Clin. 2020 Jul;9(3):345-356. doi: 10.1016/j.iccl.2020.02.007. Epub 2020 May 8.
8
Functional ambulatory status as a potential adjunctive decision-making tool following wound, level of ischemia, and severity of foot infection assessment.功能活动状态作为评估伤口、缺血程度和足部感染严重程度后的潜在辅助决策工具。
J Vasc Surg. 2020 Aug;72(2):738-746. doi: 10.1016/j.jvs.2019.11.064. Epub 2020 Apr 6.
9
Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.慢性肾脏病与外周动脉疾病下肢血运重建治疗结局。
Atherosclerosis. 2020 Mar;297:149-156. doi: 10.1016/j.atherosclerosis.2019.12.016. Epub 2019 Dec 24.
10
Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk.糖尿病血管疾病的生物标志物:脂肪-免疫系统的相互作用。
Intern Emerg Med. 2020 Apr;15(3):381-393. doi: 10.1007/s11739-019-02270-6. Epub 2020 Jan 9.